YDES

YD BIO LTD

YDES·G98301107·US·Common Stock·Healthcare - Biotechnology-13D/G

YDES (YD BIO LTD) is held by 7 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($463,817), Cerity Partners LLC ($249,526), CITADEL ADVISORS LLC ($149,765). Net institutional sentiment: Mixed.

7
Holders
Avg rating(1 Elite)
$991,991
Total Value
57% (9)
Fund Consensus
4 buying - 3 selling
YDESSmart Money Verdict
View all
Held by 7 funds
1 elite
Who's Trading
ActivistESEthan Shen77.1%Feb 17, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
60,236(+3.2%)$463,8170.0%-87.06%
17
Unchanged
32,406$249,5260.0%-87.66%
0
Increased
19,450(+68.4%)$149,7650.0%-78.86%
23
Increased
11,628(+61.7%)$89,5360.0%-84.52%
21
Increased
4,886(+94.2%)$37,6220.0%-78.29%
32
Decreased
223(-25.4%)$1,7170.0%-87.66%
0
Unchanged
1$80.0%-87.66%
0
Exited
0(-100.0%)$20,8330.0%-29.24%
0
Exited
0(-100.0%)$610.0%-29.24%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used